August 4, 2016Letter Agreement • August 10th, 2016 • Enumeral Biomedical Holdings, Inc. • Pharmaceutical preparations • Massachusetts
This letter agreement (the “Letter Agreement”) confirms that your employment with Enumeral Biomedical Holdings, Inc. (with its subsidiaries, the “Company”) has ceased effective July 28, 2016 and sets forth the terms of your separation from service as an employee of the Company. You and the Company acknowledge and agree that this separation concerns only your employment as President and Chief Executive Officer of the Company, and that you remain a director of the Company. Upon your termination as an employee of the Company, and in your continued capacity as a non-employee director of the Company, you will be entitled to participate in the Company’s Non-Employee Director Compensation Program, as may be revised from time to time by the Company’s Board of Directors or the Compensation Committee thereof. Notwithstanding anything herein to the contrary, pursuant to this letter you also hereby resign from any positions you hold as an officer and/or director of Enumeral Biomedical Corp. and En
